Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASSIOPEIR: TRK-100STP in Chronic Renal Failure
NCT01090037Phase 3Completed
- Sponsor
- Toray Industries
- Start
- Mar 2010
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial of beraprost in chronic kidney disease (CKD) (3 arms), sponsored by Toray Industries. Primary endpoint: Renal composite endpoints (Time to first occurrence of doubling of serum creatinine or ESRD). Started Mar 2010; status: completed.
02
Drugs
beraprost
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01090037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090037.